Eledon Pharmaceuticals, Inc. (ELDN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$14.94M2018: -$11.89M2019: -$13.86M2020: -$15.21M2021: -$28.91M2022: -$28.42M2023: -$39.53M2024: -$47.27M2025: -$62.34M-$62.34M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$62.34M-31.9%
2024-$47.27M-19.6%
2023-$39.53M-39.1%
2022-$28.42M+1.7%
2021-$28.91M-90.1%
2020-$15.21M-9.8%
2019-$13.86M-16.5%
2018-$11.89M+20.4%
2017-$14.94M